Literature DB >> 15390360

Characterization of karyotypic events and evolution in neuroblastoma.

David R Betts1, Ninette Cohen, Kurt E Leibundgut, Thomas Kühne, Ueli Caflisch, Jeanette Greiner, Luba Traktenbrot, Felix K Niggli.   

Abstract

BACKGROUND: Neuroblastoma (NB) is cytogenetically characterized by a number of non-random events. However, knowledge is limited concerning the timing of occurrence and inter-action of many of these events.
METHODS: Karyotypic patterns were obtained from a study group of 49 NB tumors that had been analyzed by conventional cytogenetics combined with FISH and in some instances SKY.
RESULTS: All chromosomes were involved in a numerical and structural aberration in at least one tumor. There was a positive correlation between the occurrence of MYCN and del(1p) and between del(1p) and 17q. Aberrations involving chromosomes X, 3, 19, and del(1p) could be considered early events, whereas those involving chromosomes 9, 13, 15, 18, 20, and 21 were often late events.
CONCLUSIONS: This study suggests that the karyotypic patterns characterizing NB are complex. There are aberrations that can be grouped into early or late karyotypic events, but others, such as gain of 17q, are variable.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15390360     DOI: 10.1002/pbc.20179

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma.

Authors:  Eva Villamón; Marta Piqueras; Carlos Mackintosh; Javier Alonso; Enrique de Alava; Samuel Navarro; Rosa Noguera
Journal:  Virchows Arch       Date:  2008-06-24       Impact factor: 4.064

2.  The effect of carvacrol on healthy neurons and N2a cancer cells: some biochemical, anticancerogenicity and genotoxicity studies.

Authors:  Elanur Aydın; Hasan Türkez; M Sait Keleş
Journal:  Cytotechnology       Date:  2013-04-04       Impact factor: 2.058

3.  Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas.

Authors:  David Gisselsson; Gisela Lundberg; Ingrid Ora; Mattias Höglund
Journal:  J Carcinog       Date:  2007-09-26

4.  Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism.

Authors:  Stefano J Mandriota; Linda J Valentijn; Laurence Lesne; David R Betts; Denis Marino; Mary Boudal-Khoshbeen; Wendy B London; Anne-Laure Rougemont; Edward F Attiyeh; John M Maris; Michael D Hogarty; Jan Koster; Jan J Molenaar; Rogier Versteeg; Marc Ansari; Fabienne Gumy-Pause
Journal:  Oncotarget       Date:  2015-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.